Caption Management, LLC Enanta Pharmaceuticals Inc Transaction History

Caption Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$38.13 - $76.93 $343,170 - $692,370	-9,000 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$56.06 - $74.11 $504,540 - $666,990	9,000 New	9,000 $640,000
Q4 2020 Feb 16, 2021	SELL	$41.16 - $47.47 $946,679 - $1.09 Million	-23,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$43.36 - $53.53 $433,600 - $535,300	10,000 Added 76.92%	23,000 $1.05 Million
Q2 2020 Aug 14, 2020	BUY	$46.37 - $57.58 $602,810 - $748,540	13,000 New	13,000 $652,000
Q4 2019 Feb 13, 2020	SELL	$57.95 - $66.61 $579,500 - $666,100	-10,000 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$81.3 - $97.35 $813,000 - $973,500	10,000 New	10,000 $844,000

110

21.1M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $132M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.